Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHDC7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF219 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYOM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNK15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALS2CR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SPACA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF324B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT85 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLJ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on